Answer
Nov 18, 2025 - 02:45 PM
Levobunolol was discontinued primarily due to decreased demand and the availability of alternative medications for glaucoma and ocular hypertension. There were no widespread reports of safety concerns; the decision was mainly based on market factors rather than efficacy or safety issues.
